Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2005

View Archived Issues

Data presented on the potential of KRP-203 in clinical transplantation

Minocycline accelerates the recovery of olfactory sensory neurons

mGluR5 antagonist MTEP demonstrates antiparkinsonian effects

Update on preclinical pharmacological profile of tanaproget

LGD-5552 exhibits potent antiinflammatory activity

TLR4 agonists trigger innate resistance in infectious challenge

Good results reported for the Cypher stent in complex CAD patients

Preliminary results on the efficacy of Tovaxin in multiple sclerosis

Promising phase I data on the effects and safety of BMS-188797 in solid malignancies

p38 MAP kinase: a target for pulmonary hypertension

Dual TACE/MMP inhibition is effective for arthritis

Revlimid NDA accepted for review

New license for use of paclitaxel in treatment of emphysema

Aegis Therapeutics enters into Intravail agreements

Meditech Pharmaceuticals to change name to Deli Solar

BioInvent and CAT sign license agreement

Pentoxifylline studied to stop progression of NASH

LCL-204 induces apoptosis in human prostate carcinoma cells

MorphoSys grants ImmunoGen access to HuCAL GOLD

Affitech grants license for Protein L

Boehringer Ingelheim and AbGenomics sign antibody agreement

Oxford BioMedica licenses LentiVector technology to Pfizer

Anatibant receives orphan drug designation for severe traumatic brain injury

Factive meets primary endpoint in phase III study of five-day CAP treatment

Ligand earns new milestone from GSK collaboration

Human embryonic stem cell-derived HSCs establish hematopoiesis in mice

Merck & Co. patents cover novel NR2B receptor antagonists

Recent Bayer patent describes new antiretroviral agents

New treatments for diabetes reported in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...